Global Initiative for Asthma. Global strategy for asthma management and prevention, https://ginasthma.org/wp-content/uploads/2022/05/GINA-Main-Report-2022-FINAL-22-05-03-WMS.pdf (2022).

Singh, D. Pharmacological treatment of stable chronic obstructive pulmonary disease. Respirology 26, 643–651 (2021).

Article  PubMed  Google Scholar 

Contoli, M., Morandi, L., Di Marco, F. & Carone, M. A perspective for chronic obstructive pulmonary disease (COPD) management: six key clinical questions to improve disease treatment. Expert Opin. Pharmacother. 22, 427–437 (2021).

Article  PubMed  Google Scholar 

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: 2023 report. https://goldcopd.org/wp-content/uploads/2023/03/GOLD-2023-ver-1.3-17Feb2023_WMV.pdf (2022).

Lipson, D. A. et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N. Engl. J. Med. 378, 1671–1680 (2018).

Article  CAS  PubMed  Google Scholar 

Rabe, K. F. et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N. Engl. J. Med. 383, 35–48 (2020).

Article  CAS  PubMed  Google Scholar 

Agusti, A. et al. Inhaled corticosteroids in COPD: friend or foe. Eur. Respir. J. 52, 1801219 (2018).

Article  CAS  PubMed  Google Scholar 

Miravitlles, M. et al. Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. Eur. Respir. Rev. 30, 210075 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Kumarathas, I. et al. The risk of osteoporosis in patients with asthma. Eur. Clin. Respir. J. 7, 1763612 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Dahl, R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir. Med. 100, 1307–1317 (2006).

Article  PubMed  Google Scholar 

Matera, M. G., Cardaci, V., Cazzola, M. & Rogliani, P. Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease. Expert Opin. Drug Saf. 14, 533–541 (2015).

Article  CAS  PubMed  Google Scholar 

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: 2022 report. https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf (2021).

Rabe, K. F. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176, 532–555 (2007).

Article  PubMed  Google Scholar 

Price, D., Yawn, B., Brusselle, G. & Rossi, A. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Prim. Care Respir. J. 22, 92–100 (2013).

Article  PubMed  Google Scholar 

Calverley, P. M. A., Magnussen, H., Miravitlles, M. & Wedzicha, J. A. Triple therapy in COPD: what we know and what we don’t. COPD 14, 648–662 (2017).

Article  PubMed  Google Scholar 

Koblizek, V. et al. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE study. Eur. Respir. J. 49, 1601446 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Monteagudo, M. et al. Treatment pathways before and after triple therapy in COPD: a population-based study in primary care in Spain. Arch. Bronconeumol. 57, 205–213 (2021).

Article  PubMed  Google Scholar 

Kardos, P. et al. A two-year evaluation of the 'real life' impact of COPD on patients in Germany: the DACCORD observational study. Respir. Med. 124, 57–64 (2017).

Article  PubMed  Google Scholar 

Brusselle, G. et al. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 2207–2217 (2015).

PubMed  PubMed Central  Google Scholar 

Yun, J. H. et al. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 141, 2037–2047.e10 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Buhl, R. et al. Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study. Int. J. Chron. Obstruct. Pulmon. Dis. 13, 2557–2568 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vestbo, J. et al. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population. Int. J. Chron. Obstruct. Pulmon. Dis. 14, 853–861 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vogelmeier, C. F. et al. Evaluation of exacerbations and blood eosinophils in UK and US COPD populations. Respir. Res. 20, 178 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Graf, J. et al. Medical treatment of COPD. Dtsch. Arztebl. Int. 155, 599–605 (2018).

PubMed  Google Scholar 

Cataldo, D. et al. Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice. Int. J. Chron. Obstruct. Pulmon. Dis. 13, 2089–2099 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casas, A. et al. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study. Int. J. Chron. Obstruct. Pulmon. Dis. 13, 1545–1556 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yawn, B. P., Suissa, S. & Rossi, A. Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal. NPJ Prim. Care Respir. Med. 26, 16068 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Buhl, R. et al. A year in the life of German patients with COPD: the DACCORD observational study. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 1639–1646 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Arkhipov, V., Arkhipova, D., Miravitlles, M., Lazarev, A. & Stukalina, E. Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 3255–3262 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Yawn, B. P. et al. Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 8, 295–304 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chalmers, J. D., Tebboth, A., Gayle, A., Ternouth, A. & Ramscar, N. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice. NPJ Prim. Care Respir. Med. 27, 43 (2017).

Article  PubMed  PubMed Central  Google Scholar 

White, P., Thornton, H., Pinnock, H., Georgopoulou, S. & Booth, H. P. Overtreatment of COPD with inhaled corticosteroids–implications for safety and costs: cross-sectional observational study. PLoS ONE 8, e75221 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barnes, P. J. Inhaled corticosteroids in COPD: a controversy. Respiration 80, 89–95 (2010).

Article  CAS  PubMed  Google Scholar 

Barnes, P. J. Inflammatory endotypes in COPD. Allergy 74, 1249–1256 (2019).

PubMed  Google Scholar 

Barnes, P. J. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 131, 636–645 (2013).

Article  CAS  PubMed  Google Scholar 

Burge, P. S. et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320, 1297–1303 (2000).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh, D. et al. Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials. Respir. Res. 21, 240 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brightling, C. E. et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 356, 1480–1485 (2000).

Article  CAS  PubMed  Google Scholar 

Leigh, R. et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur. Respir. J. 27, 964–971 (2006).

Article  CAS  PubMed  Google Scholar 

Singh, D. et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur. Respir. J. 44, 1697–1700 (2014).

Article  PubMed  Google Scholar 

Saha, S. & Brightling, C. E. Eosinophilic airway inflammation in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 1, 39–47 (2006).